Promisemed Hangzhou Meditech Co (BJSE:920069) EPS (Basic): ¥2.19 (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920069 Promisemed Hangzhou Meditech Co Ltd BJSE:920069
18 GF Score
Price ¥33.28
! 1 Warning Sign
View Full Analysis

What is Promisemed Hangzhou Meditech Co EPS (Basic)?

Promisemed Hangzhou Meditech Co BJSE:920069 18 EPS (Basic) is ¥2.19 as of Jun. 2026. GuruFocus rates BJSE:920069 with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

Promisemed Hangzhou Meditech Co's basic earnings per share (Basic EPS) for the three months ended in Jun. 2026 was ¥0.56. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2026 was ¥2.19.

Promisemed Hangzhou Meditech Co's EPS (Diluted) for the three months ended in Jun. 2026 was ¥0.56. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was ¥2.19.

Promisemed Hangzhou Meditech Co's EPS without NRI for the three months ended in Jun. 2026 was ¥0.58. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2026 was 2.20.

During the past 12 months, Promisemed Hangzhou Meditech Co's average EPS without NRIGrowth Rate was 8.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was 15.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Promisemed Hangzhou Meditech Co's highest 3-Year average EPS without NRI Growth Rate was 15.20% per year. The lowest was 15.20% per year. And the median was 15.20% per year.

Promisemed Hangzhou Meditech Co  (BJSE:920069) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Promisemed Hangzhou Meditech Co EPS (Basic) Related Terms

Promisemed Hangzhou Meditech Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Promisemed Hangzhou Meditech Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Promisemed Hangzhou Meditech Co EPS (Basic) Chart

Promisemed Hangzhou Meditech Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
EPS (Basic)
1.35 1.08 1.53 2.12

Promisemed Hangzhou Meditech Co Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 0.60 0.47 0.56 0.56
BJSE:920069
18GF Score
Promisemed Hangzhou Meditech Co Ltd BJSE:920069
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Promisemed Hangzhou Meditech Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Promisemed Hangzhou Meditech Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(89.776-0)/42.347
=2.12

Promisemed Hangzhou Meditech Co's Basic EPS for the quarter that ended in Jun. 2026 is calculated as

Basic EPS (Q: Jun. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(29.475-0)/52.634
=0.56

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ¥2.19 mean?
Promisemed Hangzhou Meditech Co (BJSE:920069) has a EPS (Basic) of ¥2.19 as of Jun. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Promisemed Hangzhou Meditech Co and its competitors.
Is Promisemed Hangzhou Meditech Co's EPS (Basic) too high?
Promisemed Hangzhou Meditech Co's current EPS (Basic) is ¥2.19. Overall, Promisemed Hangzhou Meditech Co has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Promisemed Hangzhou Meditech Co's EPS (Basic) compare to ISRG and BDX?
Promisemed Hangzhou Meditech Co's EPS (Basic) of ¥2.19 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Promisemed Hangzhou Meditech Co and its competitors. Promisemed Hangzhou Meditech Co's current EPS (Basic) is ¥2.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promisemed Hangzhou Meditech Co stock overvalued right now?
Promisemed Hangzhou Meditech Co (BJSE:920069) has a current EPS (Basic) of ¥2.19. The current EPS (Basic) is ¥2.19. Promisemed Hangzhou Meditech Co's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Promisemed Hangzhou Meditech Co (BJSE:920069), the current EPS (Basic) is ¥2.19 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Promisemed Hangzhou Meditech Co Business Description

Address No. 1388 Cangxing Street, Building 1, Cangqian Subdistrict, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311121
Promisemed Hangzhou Meditech Co Ltd is engaged in the Research, development, production and sales of diabetes care, universal drug delivery and infusion, and minimally invasive interventional medical devices.
18GF Score

Get the complete analysis for BJSE:920069

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥33.28
Price